Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of tumor suppressor p53 homologue TA-p63 via down regulation of its target gene, 16/April/2014, 6.58 am

Molecular cancer therapy: Radicicol/Monorden, an HSP-90 inhibitor, decreases the expression of Activator protein-1 via down regulation of its target gene, 16/April/2014, 6.46 am
April 16, 2014
Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of DNA repair protein hMSH2 via down regulation of its target gene, 16/April/2014, 7.03 am
April 16, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Molecular mechanistic insights into the treatment of metastatic Breast cancer in post- menopausal women: Fulvestrant/Faslodex, a selective estrogen receptor down-regulator, increases the expression of  tumor suppressor p53 homologue TA-p63 via down regulation of its target gene, 16/April/2014, 6.58 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.